Revvity is a global leader in developing and delivering technologies and solutions across disease pathways, focused on advancing health science and human potential. They develop cutting-edge technologies in areas like biomarker identification, multi-omics, diagnostics, and informatics, supporting critical processes from disease research to diagnostics and treatment. Serving over 2 million scientists and operating in 190 countries, Revvity aims to accelerate scientific breakthroughs that address significant health challenges.

Revolutionising Healthcare Diagnostics: A Call to Arms
A Vision for the Future of Diagnostics At Curia’s “Transforming Care, Saving Lives: Revitalising UK Life Sciences and Diagnostics” report launch, in partnership with Revvity,